Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Cerebral hypoperfusion in multiple sclerosis is reversible and mediated by endothelin-1.
Managed care aspects of managing multiple sclerosis.
Serum and cerebrospinal fluid heavy neurofilaments and antibodies against them in early multiple sclerosis.
Retrieval practice is a robust memory aid for memory-impaired patients with MS.
Safety of TNF inhibitors in adolescents and children.
Effect of high-dose 1.25 dihydroxyvitamin D3 on remyelination in the cuprizone model.
Clinical baseline factors predict response to natalizumab: their usefulness in patient selection.
Evaluating the Role of Coping Style as a Moderator of Fatigue and Risk for Future Cognitive Impairment in Multiple Sclerosis.
The neurotransmitter glutamate and human T cells: glutamate receptors and glutamate-induced direct and potent effects on normal human T cells, cancerous human leukemia and lymphoma T cells, and autoimmune human T cells.
Genomic Binding Sites and Biological Effects of the Vitamin D: VDR Complex in Multiple Sclerosis.
Intermediate uveitis in children and young adults: differences in clinical course, associations and visual outcome.
Trigeminal neuralgia: a condition to be better understood.
Genetic proof for the transient nature of the Th17 phenotype.
Myelin organization in the nodal, paranodal, and juxtaparanodal regions revealed by scanning x-ray microdiffraction.
Therapeutic potential of cannabinoid medicines.
DNase hypersensitive sites and association with multiple sclerosis.
Apparent Diffusion Coefficient Histograms in the Follow-up of Relapsing-Remitting Multiple Sclerosis.
Selective inhibition of spleen tyrosine kinase (SYK) with a novel orally bioavailable small molecule inhibitor, RO9021, impinges on various innate and adaptive immune responses: implications for SYK inhibitors in autoimmune disease therapy.
Constraint-induced movement therapy: a method for harnessing neuroplasticity to treat motor disorders.
Distilling the essence of appraisal: a mixed methods study of people with multiple sclerosis.
The Direct Effects of Fingolimod in the Central Nervous System: Implications for Relapsing Multiple Sclerosis.
Delayed P100-Like Latencies in Multiple Sclerosis: A Preliminary Investigation Using Visual Evoked Spread Spectrum Analysis.
Epoch Analysis of On-Treatment Disability Progression Events over Time in the Tysabri Observational Program (TOP).
The role of Th17 cells in patients with relapsing-remitting multiple sclerosis: Interleukin-17A and interleukin-17F serum levels.
Dynamics and Mechanisms of CNS Myelination.
Pages
« first
‹ previous
…
385
386
387
388
389
390
391
392
393
…
next ›
last »